These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


330 related items for PubMed ID: 9805908

  • 1. [Relationship between the onset and outcome of interstitial pneumonia associated with polymyositis and dermatomyositis].
    Saku N, Ohno S, Sugiyama Y, Kitamura S.
    Nihon Kokyuki Gakkai Zasshi; 1998 Jul; 36(7):585-9. PubMed ID: 9805908
    [Abstract] [Full Text] [Related]

  • 2. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
    Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF.
    Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020
    [Abstract] [Full Text] [Related]

  • 3. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
    Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, Kita Y, Kawai M, Saito Y, Iwamoto I.
    J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
    [Abstract] [Full Text] [Related]

  • 4. [Prognosis of interstitial pneumonitis (IP) in polymyositis (PM)/dermatomyositis (DM)].
    Saeki T, Suzuki E, Watanabe T, Saito Y, Itou S, Honma T, Sato T, Nakano M, Arakawa M.
    Ryumachi; 1994 Feb; 34(1):16-21. PubMed ID: 8146722
    [Abstract] [Full Text] [Related]

  • 5. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
    Fujisawa T, Suda T, Nakamura Y, Enomoto N, Ide K, Toyoshima M, Uchiyama H, Tamura R, Ida M, Yagi T, Yasuda K, Genma H, Hayakawa H, Chida K, Nakamura H.
    J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
    [Abstract] [Full Text] [Related]

  • 6. [Outcome in patients with interstitial lung disease and polymyositis-dermatomyositis--a subgroup with poor prognosis].
    Takizawa H, Suzuki N, Yanagawa T, Okazaki H, Satoh M, Akiyama N, Kohyama T, Kawasaki S, Ito K, Oka T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Oct; 34(10):1093-7. PubMed ID: 8953902
    [Abstract] [Full Text] [Related]

  • 7. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis].
    Tong SQ, Shi XH, Su JM, Zhao Y, Zhang FC.
    Zhonghua Yi Xue Za Zhi; 2006 Mar 07; 86(9):624-7. PubMed ID: 16681909
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Elevation of cytokeratin 19 fragment in patients with interstitial pneumonia associated with polymyositis/dermatomyositis.
    Fujita J, Dobashi N, Tokuda M, Bandoh S, Ohtsuki Y, Yamadori I, Yoshinouchi T, Ueda Y, Takahara J.
    J Rheumatol; 1999 Nov 07; 26(11):2377-82. PubMed ID: 10555895
    [Abstract] [Full Text] [Related]

  • 10. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
    Ji SY, Zeng FQ, Guo Q, Tan GZ, Tang HF, Luo YJ, Tang ZQ, Han YF.
    Chin Med J (Engl); 2010 Mar 05; 123(5):517-22. PubMed ID: 20367973
    [Abstract] [Full Text] [Related]

  • 11. Transbronchial biopsy is clinically useful in classifying patients with interstitial pneumonia associated with polymyositis and dermatomyositis.
    Mochimaru H, Kawamoto M, Enomoto T, Saitoh Y, Abe S, Nei T, Fukuda Y, Kudoh S.
    Respirology; 2008 Nov 05; 13(6):863-70. PubMed ID: 18811885
    [Abstract] [Full Text] [Related]

  • 12. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].
    Harigai M, Hara M, Kamatani N, Kashiwazaki S.
    Ryumachi; 1999 Dec 05; 39(6):819-28. PubMed ID: 10695405
    [Abstract] [Full Text] [Related]

  • 13. Interstitial lung disease in polymyositis and dermatomyositis.
    Marie I, Hachulla E, Chérin P, Dominique S, Hatron PY, Hellot MF, Devulder B, Herson S, Levesque H, Courtois H.
    Arthritis Rheum; 2002 Dec 15; 47(6):614-22. PubMed ID: 12522835
    [Abstract] [Full Text] [Related]

  • 14. [Risk factors associated with cardiac involvement in patients with dermatomyositis/polymyositis].
    Zuo C, Wei XD, Ye YL, Liang Y, Yin G, Yang M, Xie QB.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep 15; 44(5):801-4, 809. PubMed ID: 24325116
    [Abstract] [Full Text] [Related]

  • 15. Polymyositis-dermatomyositis-associated interstitial lung disease.
    Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR, Ryu JH.
    Am J Respir Crit Care Med; 2001 Oct 01; 164(7):1182-5. PubMed ID: 11673206
    [Abstract] [Full Text] [Related]

  • 16. Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia--with or without PM/DM.
    Takato H, Waseda Y, Watanabe S, Inuzuka K, Katayama N, Ichikawa Y, Yasui M, Fujimura M.
    Respir Med; 2013 Jan 01; 107(1):128-33. PubMed ID: 23137883
    [Abstract] [Full Text] [Related]

  • 17. [A case of interstitial pneumonia of polymyositis-dermatomyositis with various pathological findings in open lung biopsy].
    Mouri M, Nambu Y, Matsui M, Kobayashi Y, Kishimoto N, Noguchi T, Matsuda M, Sakurai S, Ohya N.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 May 01; 31(5):629-35. PubMed ID: 8331851
    [Abstract] [Full Text] [Related]

  • 18. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
    Chen F, Shu XM, Wang DX, Xie Y, Wang GC.
    Zhonghua Yi Xue Za Zhi; 2012 Aug 21; 92(31):2182-5. PubMed ID: 23158422
    [Abstract] [Full Text] [Related]

  • 19. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].
    Wang PZ, Guan JL, Han XH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun 21; 31(6):417-20. PubMed ID: 19031800
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.